Q4 2025 earnings call recap: provider growth, Evolent ACO deal, 2026 EBITDA/free cash flow guidance, key risks—read now.
Q4 2025 earnings call recap: revenue, procedure growth, 2026 guidance, margin drivers & risks from sales changes—read now.
Thank you, and welcome, everyone, to Agilent Technologies, Inc.'s conference call for 2026. With me on the line are CEO, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results